Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mycolic acid synthesis refers to the biosynthetic pathway responsible for producing mycolic acids—very long-chain, branched fatty acids that are essential components of the cell wall in Mycobacterium species, including *Mycobacterium tuberculosis*. This pathway involves several key enzymes including FAS-I, FAS-II, Acc, FadD32, Pks13, and CmrA. Inhibiting this pathway is a validated therapeutic strategy for tuberculosis.
Inhibition of enzymes involved in mycolic acid synthesis, such as FAS-I, FAS-II, Acc, FadD32, Pks13, or CmrA
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycolic Acid Synthesis Pathway (MAS Pathway).